Photopheresis therapy for cutaneous T-cell lymphoma

Journal of the American Academy of Dermatology

Volumn 35, Issue 4, 1996, Pages 573-579

  Duvic, Madeleine ^a,b   Hester, Jeane P ^b   Lemak, Noreen A ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER REGRESSION; CLINICAL ARTICLE; HELPER CELL; HUMAN; PRIORITY JOURNAL; PUVA; T CELL LYMPHOMA; TREATMENT OUTCOME;

EID: 0030479231     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(96)90683-0     Document Type: Article

References (27)

1. Edelson RL, Berger CL, Raafat J, et al. Karyotype studies of cutaneous T cell lymphoma: evidence for clonal origin. J Invest Dermatol 1979;73:548-50.
2. Epstein EH Jr, Levin DL, Croft JD Jr, et al. Mycosis fungoides: survival, prognostic features, response to therapy and autopsy findings. Medicine (Baltimore) 1972;51:61-72.
3. Winkler CF, Sausville EA, Ihde DC, et al. Combined modality treatment of cutaneous T cell lymphoma: results of a 6-year follow-up. J Clin Oncol 1986;4:1094-100.
4. Weinstock MA, Horm JW. Population-based estimate of survival and determinants of prognosis in patients with mycosis fungoides. Cancer 1988;62:1658-61.
5. Sausville EA, Eddy JL, Makuch RW, et al. Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome: definition of three distinctive prognostic groups. Ann Intern Med 1988;109:372-82.
6. Cohen SR, Stenn KS, Braverman IM, et al. Mycosis fungoides: clinicopathologic relationships, survival, and therapy in 59 patients with observations on occupation as a new prognostic factor. Cancer 1980;46:2654-66.
7. Pancake BA, Zucker-Franklin D, Coutavas EE. The cutaneous T cell lymphoma, mycosis fungoides, is a human T cell lymphotropic virus-associated disease: a study of 50 patients. J Clin Invest 1995;95:547-54.
8. Edelson R, Berger C, Gasparro F, et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. N Engl J Med 1987;316:297-303.
9. Edelson R, Heald P, Perez M, et al. Photopheresis update. Prog Dermatol 1991;25:1-6.
10. Zic J, Arzubiaga C, Salhany KE, et al. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma. J Am Acad Dermatol 1992;27:729-36.
11. Rook AH, Wolfe JT. Role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection. J Clin Apheresis 1994;9:28-30.
12. Armus S, Keyes B, Cahill C, et al. Photopheresis for the treatment of cutaneous T cell lymphoma. J Am Acad Dermatol 1990;23:898-902.
13. Oziemski MA, Rockman SP, Marks DI, et al. Extracorporeal photochemotherapy in the treatment of cutaneous T-cell lymphoma: complexity of objective evaluation. Int J Dermatol 1991;30:814-7.
14. Heald PW, Perez MI, Christensen I, et al. Photopheresis therapy of cutaneous T-cell lymphoma: the Yale-New Haven Hospital experience. Yale J Biol Med 1989;62:629-38.
15. Lamberg SI, Green SB, Byar DP, et al. Clinical staging for cutaneous T-cell lymphoma. Ann Intern Med 1984; 100:187-92.
16. Patterson JAK, Edelson RL. Cutaneous T-cell lymphoma and other leukemic and lymphomatous infiltrates of the skin. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al, editors. Dermatology in general medicine. New York: McGraw-Hill, 1986:1086-118.
17. Salhany KE, Greer JP, Cousar JB, et al. Marrow involvement in cutaneous T-cell lymphoma: a clinicopathologic study of 60 cases. Am J Clin Pathol 1989;92: 747-54.
18. Blaylock WK, Clendenning WE, Carbone PP, et al. Normal immunologic reactivity in patients with the lymphoma mycosis fungoides. Cancer 1966;19:233-6.
19. Bertness V, Kirsch I, Hollis G, et al. T-cell receptor gene rearrangements as clinical markers of human T-cell lymphomas. N Engl J Med 1985;313:534-8.
20. Weiss LM, Hu E, Wood GS, et al. Clonal rearrangements of T-cell receptor genes in mycosis fungoides and dermatopathic lymphadenopathy. N Engl J Med 1985; 313:539-44.
21. Christensen I, Heald P. Photopheresis in the 1990s. J Clin Apheresis 1991;6:216-20.
22. Edelson RL. Light-activated drugs. Sci Am 1988;259:68-75.
23. Knobler RM, Trautinger F, Graninger W, et al. Patenteral administration of 8-methoxypsoralen in photopheresis. J Am Acad Dermatol 1993;28:580-4.
24. Heald P, Yan S-L, Edelson R. Profound deficiency in normal circulating T cells in erythrodermic cutaneous T-cell lymphoma. Arch Dermatol 1994;130:198-203.
25. Vowels BR, Cassin M, Boufal MH, et al. Extracorporeal photochemotherapy induces the production of tumor necrosis factor-alpha by monocytes: implications for the treatment of cutaneous T-cell lymphoma and systemic sclerosis. J Invest Dermatol 1992;98:686-92.
26. Tharp M, Whiteside T, Charley M, et al. In vitro sensitivity of Sézary cells to natural cytotoxicity [abstract]. J Invest Dermatol 1989;92:531.
27. Marks DI, Rockman SP, Oziemski MA, et al. Mechanisms of lymphocytotoxicity induced by extracorporeal photochemotherapy for cutaneous T cell lymphoma. J Clin Invest 1990;86:2080-5.